key: cord-1029493-13zpjwfu
authors: Li, Jin-Yan; Wang, Qiong; Liao, Ce-Heng; Qiu, Ye; Ge, Xing-Yi
title: The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses
date: 2021-01-18
journal: Virus Res
DOI: 10.1016/j.virusres.2021.198307
sha: 2c2fcd600c27c12c2a0b0b23eef3c4243b809641
doc_id: 1029493
cord_uid: 13zpjwfu

Bats carry diverse severe acute respiratory syndrome-related coronaviruses (SARSr-CoVs). The possible interspecies transmission of SARSr-CoVs from bats to humans has caused two severe CoV pandemics, the SARS pandemic in 2003 and the recent COVID-19 pandemic. The receptor utilization of SARSr-CoV plays the key role in viral infection in determining the host range and the interspecies transmission ability of the virus. Both the SARS-CoV and SARS-CoV-2 use angiotensin-converting enzyme 2 (ACE2) as their receptor. Previous studies showed that WIV1 strain, the first living coronavirus isolated from bat using ACE2 as its receptor, is the prototype of SARS-CoV. The receptor-binding domain (RBD) in the spike protein (S) of SARS-CoV and WIV1 is responsible for ACE2 binding and medicates the viral entry. Comparing to human SARS-CoV, the bat WIV1 has three distinct amino acid residues (442, 472, and 487) in RBD. This study aimed at exploring whether these three residues could alter the receptor utilization of SARSr-CoVs. We replaced the three residues in SARS-CoV (BJ01 strain) S with their counterparts in WIV1 S, and then evaluated the change of their utilization of bat, civet, and human ACE2s using a lentiviral pseudovirus infection system. To further validate the S-ACE2 interactions, the binding affinity between the RBDs of these S proteins and different ACE2s were verified by flow cytometry. The results showed that the single amino acid substitution Y442S in the RBD of the SARS-CoV BJ01 spike protein enhanced its utilization of bat ACE2 and its binding affinity to bat ACE2. On the contrary, the reverse substitution in WIV1 S (S442Y) significantly attenuated the pseudovirus utilization of bat, civet and human ACE2s for cell entry, and the binding affinity was also decreased notably. These results suggest that the S442 is critical for WIV1 adapting in bats as its natural host. These findings will enhance our understanding of host adaptations and cross-species infections of coronaviruses, contributing to the prediction and prevention of coronavirus epidemics.

some strains of bat SARSr-CoVs use ACE2 as their receptor, and may be the direct ancestor of SARS-CoV and the potential pathogens for future outbreaks of CoV epidemics (Ge et al., 2013; Menachery et al., 2016; Yang et al., 2016) . Especially, the CoVs from Rhinolophus sinicus are the most closest to SARS-CoV, which is worth more attention.

Spike (S) proteins of CoVs are responsible for cell recognition and host adaptation (Gui et al., 2017) . The S protein can be cleaved by proteases into an N-terminal S1 subunit for receptor recognition and binding, and a C-terminal S2 region mediating fusion of the virus and host cell membranes (Belouzard et al., 2009; Bertram et al., 2011) . CoVs are the RNA viruses with insufficient proofreading capability, which leads to high mutation rate, driving viral evolution and genome variability. Especially, mutations in the S protein of CoVs impose the major effect on viral infectivity and host range. For example, recent research reported that the furin protease cleavage site and the mutation D614G of SARS-CoV-2 enhances viral infectivity and increases transduction of multiple human cell types, raising the concern about the existence of more highly transmissible or more virulent SARS-CoV-2 forms in the future (Daniloski et al., 2020; Plante et al., 2020; Wang et al., 2020b; Zhang et al., 2020) .

The defined receptor-binding domain (RBD) includes a 193-residue fragment (amino acids 318 to 510) in the SARS-CoV S1 domain, which is more sufficient for high-affinity binding to ACE2 than does the full S1 domain (Babcock et al., 2004; Wong et al., 2004; Xiao et al., 2003) . In essence, RBD determines cellular receptor recognition, cell tropism, and host specificity. For instance, bat SARSr-CoV Rp3 S protein cannot use ACE2 for cell entry regardless of the origin of the ACE2 molecule (Ren et al., 2008) . However, after replacing the RBD with SARS-CoV S proteins, bat SARSr-CoV Rp3 can recognize AEC2 receptor and replicate efficiently (Becker et al., 2008; Ren et al., 2008) . In addition, genetic variance of the RBD can cause viral virulence alteration and cross-species infections. Even minor changes in amino acid residues of the RBD of SARS-CoV S protein are able to alter the host range of several coronaviruses. For instance, there are four prototypic SARS-CoV strains: hTor02 (a . The affinity of their RBDs to human ACE2 varies, but all of them show a high affinity for the civet ACE2. As a result, humans are most susceptible to hTor02, moderately susceptible to hGd03, and poorly susceptible to cSz02 and cGd05, while civets are susceptible to all four viral strains (Liu et al., 2007) . Especially, there were two key residues (amino acids 479 and 487) alteration in S proteins of SARS-CoV isolated during minor 2003-2004 outbreak, probably explaining why the virus had failed to transmit from human to human (Li, 2008; Li et al., 2005b) . Collectively, CoV spike protein mutations are capable of influencing host range and cross-species transmission.

Interactions between five residues (amino acids 442, 472, 479, 487 and 491) in RBD and four ACE2 residues (residues 31, 35, 38, and 353) are important for SARS progression and tropism (Li, 2008; Li, 2013; Wu et al., 2012) . In the present study, three residues (amino acids 442, 472, and 487) were different between SARS-CoV BJ01 and SARSr-CoV WIV1. In order to explore whether these three residues could alter the host range of SARS-CoV, we substituted these three residues in SARS-CoV (BJ01 strain) RBD with the corresponding residues of WIV1 RBD, and then evaluating the change of their capability mediating cell entry of pseudovirus using bat, civet, and human ACE2s. Meanwhile, the abilities of SARS-CoV, SARSr-CoV receptor-binding domain (RBD) and their mutants to bind to different ACE2 were verified by protein binding experiments. This study identified that 442th residue of the spike protein of SARSr-CoV is critical for host adaptation and interspecies transmission. Thus, insight into the mutation rate of the S protein is essential to understanding the host rang and infection of SARS-CoV. Moreover, knowing about these residues may be helpful for assessing the risk of new SARSr-CoV outbreak in the future.

J o u r n a l P r e -p r o o f 2.1. Cell culture HEK293T, GP2-293, HeLa and Vero-E6 cells were cultured in DMEM (Gibco Grand Island, USA) supplemented with 10% fetal bovine serum (FBS) (Gibco). All cells were maintained at 37 °C in a humidified incubator containing 5% CO2.

Firstly, the full length ACE2 genes of human, civet, and R. sinicus bat (GenBank number KC881004.1) were cloned into pQCXIH vector with the C-terminal HA tag.

Secondly, 3 µg retroviral expression vectors (VSV-G) and 3 µg expression plasmids (pQCXIH-h/b/c-ACE2-HA) were cotransfected into GP2-293 cells seeded in 6 cm cell dish using Lipofectamine 2000 (Invitrogen, USA) respectively. After 6 h transfection, media was removed and replaced with fresh DMEM with 10% FBS.

After 48 h, viral supernatants were harvested and then cleared cell debris by centrifugation. Following filtrated through a 0.45 µM sterilized membrane (Millipore, USA), and finally aliquots were stored at -80 °C.

HeLa cells were seeded in 6-well plates and grown for 18 h to reach ~70% confluence, discarding the cell culture supernatant, infected by 2 mL virus for 7 h, then replaced the virus with the growth medium containing 250 µg/mL hygromycin to eliminate the non ACE2-expressing cells. Hygromycin-resistant clones were validated via western blot (WB) and immunofluorescence assay (IFA).

HeLa cells stably expressing human, civet and bat ACE2 were seeded on coverslips in 24-well plates (Corning, USA). The following day, the cells were washed with PBS twice and fixed with 4% formaldehyde for 15 min, then permeabilized with 0.2% triton-100 for 5 min at room temperature, after being blocked with 3% BSA for 1h, the cells were incubated with mouse anti-HA antibody (CST, USA) at 4 °C overnight followed by incubation with Alexa 555-conjugated goat anti-mouse IgG (Invitrogen, USA) at room temperature for 30 min. Finally, cells were incubated with DAPI (Sigma, USA) for 10 min at room temperature for nuclear staining. Each incubation step was followed by washing with PBS three times. After the final wash, the slides J o u r n a l P r e -p r o o f were fixed with 3 µL fluorescent quencher and observed under a confocal microscope (Nikon, Japan).

By comparing the S sequences of BJ01 (GenBank number AY278488) and WIVI (GenBank number KC881007)，the sequence of the BJ01 strain was chosen to generate a series of BJ01 variants using site-directed mutagenesis method. The mutated amino acid codon for each mutant is presented as follows: Y442S, L472F, T487N, Y442S/L472F, Y442S/T487N, L472F/T487N, Y442S/L472F/T487N. In addition, the WIV1 strain was chosen to generate the variant S442Y, the Rp3 strain (GenBank number DQ071615) serves as the negative control.

HIV-based pseudoviruses carrying the S protein were prepared as described previously (Nie et al., 2004) . Briefly, 15 µg plasmids containing the respective S gene or mutants (in vector pcDNA3.1) and 10 µg HIV backbone plasmid (pNL4-3.luc.RE) were cotransfected into HEK 293T cells using Polyethylenimine/PEI (Polysciences, USA). After 6 h transfection, the medium was replaced with fresh media. Next, the cell culture supernatant was collected after 48 h transfection, and the cell debris was cleared by centrifugation and further removed by passing through a 0.45 µm filter (Millipore). HIV-1-pseudotyped virus were aliquoted and stored at -80 °C.

Pseudoviruses was separated on a 10% SDS-PAGE gel and transferred to a PVDF membrane (Millipore). After blocking with 5% skimmed milk in PBS and incubated with antibody against the SARS Coronavirus Spike Protein Polyclonal Antibody (Invitrogen, USA) and anti-p24 antibodies (Abnova, USA) at 4 °C for 12 h. The membrane was washed three times with PBS containing Tween-20 (0.1%) followed by incubation with horseradish peroxidase-conjugated secondary antibody diluted 1:5000. Then, the membrane was washed three times and proteins were visualized with the SuperSignal West Pico PLUS Chemiluminescent Substrate (Thermo Fisher Scientific).

A human immunodeficiency virus (HIV)-based pseudovirus system was employed J o u r n a l P r e -p r o o f to compare difference in receptor usage between SARSr-CoV WIV1, SARS-CoV BJ01 and their mutants. The luciferase activity was measured using the luciferase assay system (Promega, USA), which was expressed from the reporter gene carried by the pseudovirus. Briefly, cells were lysed after infection 48 h by adding 60 µL of lysis buffer provided with the kit, and then 20 µL of the resulting lysates were added to 20 µL of luciferase substrate, mixed thoroughly and measured for luciferase activity.

Each infection experiment was conducted in triplicate.

First of all, the RBD sequences (residues 317-569) of the BJ01 strain were cloned into pCAGGS vector, introducing a secretion signal peptide and an S-tag in order to subsequent experiment. Similarly, a series of RBD mutants in the same site were generated by the same method. Secondly, a series of RBD variants were conducted and then transfected into human embryonic kidney HEK293T cells cultured in 10 cm dishes using PEI, further cultured with 293 SFM II-based expression medium (Life Technologies) for 48 h. The RBD protein in supernatants and cell lysis were detected by western blot using anti-S antibodies, respectively. Next, Large-scale supernatants containing the soluble RBD proteins were harvested, cleared the cell debris by centrifugation, and filtrated through a 0.45 µm sterilized membrane, then added S-protein Agarose (Millipore, USA) and incubated for 1 h at room temperature. The Agarose was added into the column with filter cartridge and eluted with 3 M MgCl2.

The purified protein was concentrated by ultrafiltration using an ultrafiltration tube (Millipore, USA) and then dissolved in PBS. Finally, the concentration of purified RBDs was quantified by BCA assay, and then the purified RBDs were aliquoted.

To measure the binding affinity between various RBD protein and bACE2, cACE2 and hACE2. HeLa cells stably expressing bACE2, cACE2 and hACE2 were seeded in 10 cm dishes. Discarding the cell culture supernatant and washing twice with PBS after 18 h, the cells were digested from culture dishes using 5 mM EDTA solution, and incubated with purified various S-tagged RBD proteins (5 µg) for 1 h at room J o u r n a l P r e -p r o o f temperature, following blocked with PBS supplemented by 3% BSA for 30 min.

Subsequently, the cells were resuspended in 200 µL of PBS with 2% FBS containing DyLight® 488-labeled anti-S antibodies (Abcam, UK) and incubated for 1 h at room temperature in dark. The fluorescence intensity was performed using a Gallios cytometer (Beckman Coulter) by counting 20 000 events.

In order to investigate the host receptor adaptations and cross-species infections, HeLa cells, a cell line not expressing ACE2 natively, were used to establish stable cell lines expressing human, civet and bat ACE2 (hACE2, cACE2, and bACE2). Western blot analysis indicated that all the three stable cell lines showed similar levels of ACE2 expression which were higher than transiently transfected cells (Fig. 1A) .

Immunofluorescence assay showed that stable expression of hACE2, cACE2, and bACE2s were localized to the cell membrane (Fig. 1B) . Taken all together, the stable cell lines expressing hACE2, cACE2, and bACE2 were established successfully.

Previous structure and genetic analyses reported that five key residues (amino acids 442, 472, 479, 487 and 491) in the RBD of the SARS-CoV S protein play an essential role in receptor binding (Wu et al., 2012) . The S of SARS-CoV BJ01 is different from that of SARSr-CoV WIV1 at three residues of amino acids which are residues 442, 472, and 487 ( Fig. 2A) . In order to explore the role of these three residues in receptor binding, the 442th (Tyr, Y), 472th (Leu, L) and 487th (Thr, T) residues in the BJ01 spike was replaced by the WIV1 counterpart residues 442 (Ser, S), 472 (Phe, F) and 487 (Asn, N), respectively, and the double and triple substitutions were also generated.

As shown in Fig. 2B , these substitutions had no effect on the expression of S proteins.

Subsequently, we prepared pseudotyped viruses harboring these S proteins and verified the packaging efficiency of pseudoviruses by western-blot using SARS coronavirus spike protein polyclonal antibody (Fig. 2B) . The pseudovirus infectivity J o u r n a l P r e -p r o o f was tested on Vero-E6 cells, a cell line expressing ACE2 natively. As shown in Fig.   2C , pseudoviruses expressing BJ01-S and WIV1-S entered Vero-E6 efficiently, while Rp3 pseudoviruses could not infect Vero E6 cells, as reported previously (Ren et al., 2008) . Then we carried out the pseudovirus entry assay using HeLa cells stably expressing hACE2, cACE2, and bACE2. The results showed that WIV1 pseudovirus could efficiently infect all the HeLa cell lines expressing hACE2, cACE2, and bACE2.

In contrast, BJ01 pseudovirus efficiently utilized hACE2 and cACE2 but used bACE2 less efficiently, which is consistent with previous reports (Ren et al., 2008) . In addition, the BJ01 mutants had no significant change in entering cells expressing protein was made and its utilization efficiency of bACE2, cACE2 and hACE2s was tested. The result showed that S442Y substitution on WIV1 S proteins greatly attenuated its infection to HeLa cells expressing all the three ACE2s (Fig. 2C) .

Collectively, Y442 is critical for the utilization of bat ACE2 by SARS-CoV BJ01 and SARSr-CoV WIV1.

In order to further confirm the binding ability of ACE2s to different RBD mutants, a series of RBD mutants were constructed and used for binding assay. As shown in Fig. 3A and B, a series of RBD and mutant proteins were detected not only in the cell lysate, but also in the cell supernatants, suggesting that the cells could secrete soluble RBD protein into the cell supernatant successfully. Subsequently, the RBDs were purified from supernatants. The purified RBDs were also characterized by western blot and coomassie blue staining, which showed the correct size of the 37 kDa.

Interestingly, we observed two bands for RP3 RBD, the lower band is about 35 kDa J o u r n a l P r e -p r o o f smaller than the other RBDs as expected since RP3 RBD is 19 amino-acid shorter ( Fig. 3C and D) . The series of soluble purified RBDs were used in following flow cytometric experiment.

To further assess the host adaption of genetic variations in the RBD domain, the binding ability between a series of equivalent amount of RBDs and stable cell lines expressing ACE2 was analyzed by flow cytometry. As shown in Fig. 4 , both RBDs of SARS-CoV BJ01 and SARSr-CoV WIV1 could bind to hACE2 and cACE2 efficiently. In contrast, the binding affinity of BJ01-RBD and WIV1-RBD to bACE2 was less than hACE2 and cACE2. Interestingly, we found that the mutants of Y442S, Y442S/L472F, Y442S/T487N and Y442S/L472F/T487N could increase the binding affinity between BJ01-RBD and bACE2, but the other three mutants L472F, T487N and L472F /T487N had no effect. Compared to the wild-type WIV1, the single amino acid substitution S442Y could greatly reduce the interaction of WIV1 RBD with bACE2, cACE2 and hACE2, consistent with pseudovirus assay results. Compared with the wild-type BJ01, the single amino acid substitution (Y442S and L472F) of SARS-CoV BJ01 slightly increased their affinity to hACE2, but reduced their affinity to cACE2. Mutation T487N decreases the RBD/hACE2 and the RBD/cACE2 affinity obviously. In addition, introduction of WIV1 residues at 487 in BJ01 RBD (Y442S/ T487N, L472F/ T487N and Y442S/L472F/T487N) decreased the RBD/hACE2 and the RBD/cACE2 affinity to various levels. As the negative control, the RBD of SARSr-CoV Rp3 showed almost no binding ability to any ACE2s.

The spike protein of coronavirus is responsible for receptor recognition, binding and facilitating viral cell entry, which are the key steps for infection, host range and cross-species transmission of the virus (Li et al., 2005a) . During the transmission of SARS-CoV from its natural reservoir (bats) to the intermediate host (civets), and then the final host (humans), the S protein is under the strong positive selection to adapt to J o u r n a l P r e -p r o o f different viral hosts, and the key nonsynonymous variations in the S gene are mainly located within the RBD (Qu et al., 2005) . This study was focused on 3 residues (amino acids 442, 472, and 487) of human SARS-CoV BJ01 RBD distinct from bat SARSr-CoV WIV1 RBD that may be responsible for the host adaption.

In this study, the effects of the spike variations on SARS-CoV BJ01 infectivity in hACE2, cACE2, and bACE2 cells were investigated by the pseudovirus system. Correspondingly, the binding affinity between WIV1-RBD and the ACE2s was also greatly decreased. Taken together, the substitutions at positions 442 is essential for receptor binding and utilization.

Furthermore, the single amino acid substitutions Y442S and L472F in SARS-CoV BJ01 RBD enhanced their affinity to hACE2, possibly owing to the affinities of RBD/hACE2 interfaces. Based on the structural interactions, the Y442 of SARS-CoV has partial steric clash with alkyl side chain of hACE2 L31, while the substitution Y442S partially relieves this steric clash and strengthens the structure of hotspot-31, in addition, alcohol hydroxyl group of serine has a higher affinity with the amino of J o u r n a l P r e -p r o o f lysine than the phenolic hydroxyl group of tyrosine (Li, 2013) . In addition, L472F may make stronger van der Waals contact with M82 and thus further slightly strengthens RBD/hACE2 interactions. As for RBD/cACE2 interfaces, RBD residue Y442 forms a hydrogen bond with T31 and thereby binds to cACE2 efficiently. F472 would have partial steric clash with the hydroxyl group of chimeric ACE2 T82 (Wu et al., 2012) . Therefore, the single amino acid mutation Y442S or L472F slightly decreases the RBD/cACE2 binding affinity. Furthermore, mutation T487N of the human SARS-CoV BJ01 which mimics WIV1 RBD significantly decreases the RBD/hACE2 and RBD/cACE2 binding affinity. The methyl group of T487 is capable of forming salt bridge with D38 and K353 of hACE2 in a hydrophobic environment, while T487N removes an energetically favorable hydrophobic interaction with hACE2 K353 and becomes difficult for formation of the salt bridge (Li, 2008) .

Similarly, the methyl group of T487 also supports the cACE2 K353-E38 salt bridge, and thus, mutation T487N blocks the formation of the salt bridge (Wu et al., 2012) .

Introduction of WIV1 residues at 487, the BJ01 RBD mutants Y442S/T487N, L472F/T487N and Y442S/L472F/T487N lower the RBD/hACE2 and RBD/cACE2 binding affinity to various levels. Therefore, T487 is essential for high affinity association with hACE2 and cACE2, which is critical or sufficient for the adaptation of SARS-CoV to human cells (Li et al., 2005b) . However, there are some shortcomings in this study, some protein binding data were not consistent with pseudovirus-entry results, which may be due to the different mechanisms of the two assays. Briefly, peusodvirus entry depends on not only RBD-ACE2 binding but also other steps such as membrane fusion and particle internalization. In addition, the purified monomeric or oligomeric soluble RBD protein may be not completely consistent with their natural conformation. Living virus infection could verify the results in the future. Interestingly, there are two bands for RP3 RBD, which may be caused by the special amino acid sequence characteristics of this protein, resulting in post-translational modification or cleaving, or other particular reasons unknown and potentially leading to the distinct receptor utilization of ACE2.

Bats are highly diverse with the second largest number of species in mammals, carrying a wide variety of coronaviruses (Burgin et al., 2018; Wong et al., 2019) . Bats are the only group of mammals capable of flying, which allows bats to disseminate the viruses widely and enhances the chance of interspecies transmission (Woo et al., 2012) . Moreover, coronaviruses are capable of adapting to new hosts through amino acid residue changes in RBD domain with relative shortcuts which could facilitate cross-species infections and human-to-human transmission (Drexler et al., 2014; Luk et al., 2019) . In addition, SARS-CoV, SARS-CoV-2 and some of the other SARSr-CoVs could use ACE2 as the receptor of many mammal species with different utilization efficiency, which indicates broad host range of these viruses (Qiu et al., 2020; Wang et al., 2020a) . Therefore, health threats from coronaviruses are constant and long-term . Research on the RBD/receptor interactions could assess the viral infectivity and provide theoretical basis for vaccine development and others.

This work was jointly funded by the National Natural Science Foundation of China 

Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor

Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites

Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease

How many species of mammals are there

Origin and evolution of pathogenic coronaviruses

The D614G mutation in SARS-CoV-2 Spike increases transduction of multiple human cell types

Genomic Characterization of Severe Acute Respiratory Syndrome-Related Coronavirus in European Bats and Classification of Coronaviruses Based on Partial RNA-Dependent RNA Polymerase Gene Sequences

Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections

Receptor recognition and cross-species infections of SARS coronavirus

The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future

The Impact of Mutations in SARS-CoV-2 Spike on

Bats are natural reservoirs of SARS-like coronaviruses

Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2

Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Molecular epidemiology, evolution and phylogeny of SARS coronavirus

SARS-like WIV1-CoV poised for human emergence

Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression

Spike mutation D614G alters SARS-CoV-2 fitness

Predicting the angiotensin converting enzyme 2 (ACE2) utilizing as the of SARS-CoV-2

Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy

Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin

Detection of novel SARS-like and other coronaviruses in bats from Kenya

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Receptor utilization of angiotensin-converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

Global Epidemiology of Bat Coronaviruses

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus

A new coronavirus associated with human respiratory disease in China

Mechanisms of host receptor adaptation by Severe Acute Respiratory Syndrome Coronavirus

The sars-cov s glycoprotein: expression and functional characterization

Isolation and characterization of a novel bat coronavirus closely related to the direct progenitor of Severe Acute Respiratory Syndrome Coronavirus

The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity

Lane 1: HeLa cell acts as a negative control; Lanes 2 to 4: transient transfection of cells expressing civet, bat and human ACE2; Lanes 4 to 6: stable expression of civet, bat and human ACE2 cell. (B) HeLa cells stably expressing civet, bat and human ACE2 were verified by immunofluorescence. ACE2 expression was detected with mouse anti-HA antibody followed by Alexa 555-conjugated goat anti-mouse IgG. Nuclei were stained with DAPI (6-diamidino-2-phenylindole). The top row shows HeLa cells as a negative control. Rows 2 to 4 show HeLa cells stably expressing hACE2, bACE2, and cACE2. The columns (from left to right) show cells of brightfield, staining of cell nuclei (blue), staining of expressed

Foundation of Hunan Province [grant number 2019JJ20004, and 2019JJ50035].

GXY and LJY designed the experiments. LJY and WQ carried out the experiments.LJY, LCH, QY and GXY analyzed the data. LJY, QY, and GXY wrote the paper. All the authors approved the final manuscript.

The authors declare that they have no conflict of interest.

The authors declare no conflict of interest.J o u r n a l P r e -p r o o f